STOCK TITAN

INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
INOVIO to Release Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
Positive
  • None.
Negative
  • None.

PLYMOUTH MEETING, Pa., Feb. 21, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that fourth quarter and year-end 2023 financial results will be released after the market close on March 6, 2024. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss financial results and provide a general business update.

The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

Contacts
Media: Jennie Willson (267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267) 440-4298 thomas.hong@inovio.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-report-fourth-quarter-and-year-end-2023-financial-results-on-march-6-2024-302066820.html

SOURCE INOVIO Pharmaceuticals, Inc.

FAQ

When will INOVIO release its fourth quarter and year-end 2023 financial results?

INOVIO will release its fourth quarter and year-end 2023 financial results after the market close on March 6, 2024.

What diseases does INOVIO focus on treating and protecting people from?

INOVIO focuses on developing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases.

Where can I listen to the live conference call and webcast discussing INOVIO's financial results?

You can listen to the live conference call and webcast discussing INOVIO's financial results online at http://ir.inovio.com/events-and-presentations/default.aspx.

Will there be a live Q&A session with analysts during the webcast?

Yes, there will be a live Q&A session with analysts during the webcast.

For how long will the webcast be available for replay?

The webcast will be archived and available for replay for 90 days following the event.

Inovio Pharmaceuticals, Inc.

NASDAQ:INO

INO Rankings

INO Latest News

INO Stock Data

331.35M
22.99M
1.61%
17.98%
9%
Small Arms, Ordnance, and Ordnance Accessories Manufacturing
Manufacturing
Link
United States of America
SAN DIEGO

About INO

inovio is revolutionizing the fight against cancer and infectious diseases. our immunotherapies uniquely activate best-in-class immune responses to prevent and treat disease, and have shown clinically significant efficacy with a favorable safety profile. with an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. partners and collaborators include roche, medimmune, university of pennsylvania, darpa, drexel university, nih, hiv vaccines trial network, national cancer institute, u.s. military hiv research program, and university of manitoba. for more information, visit www.inovio.com.